# Natco Pharma Ltd. - Chemical Division – FDA Inspection, Aug 9, 2019

Source: https://www.keypedia.com/records/fda_inspections/natco-pharma-ltd-chemical-division/f3508ce8-cdfe-42a8-acd7-8d4dd110fcb9
Source feed: FDA_Inspections

> FDA inspection 1099291 of Natco Pharma Ltd. - Chemical Division, August 09, 2019. Classification: Voluntary Action Indicated (VAI). Form 483 issued. 4 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1099291
- Company Name: Natco Pharma Ltd. - Chemical Division
- Inspection Date: 2019-08-09
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1275209 - 2025-06-13](https://www.keypedia.com/records/fda_inspections/natco-pharma-ltd-chemical-division/fe9a831b-e0da-4681-ae9a-15851f2fff24)
- FDA Inspection 1052872 - 2018-02-16
- FDA Inspection 903169 - 2014-10-13
- FDA Inspection 762071 - 2011-11-24

## Related Officers

- [Yvins Dezan](https://www.keypedia.com/people/yvins-dezan/e9fd12e6-c090-4eb6-bc78-8b80e8a90946)

Company: https://www.keypedia.com/companies/natco-pharma-ltd-chemical-division/3d56c2ac-4a7d-4f9f-8987-966d0ff5e5f1

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c